Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials
- 23 May 2018
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 38 (6) , 674-687
Abstract
Commonly prescribed durations of therapy for many, if not most, bacterial infections are not evidence‐based. Misunderstandings by clinicians and patients alike influence perspectives on antibiotic use, including duration of therapy and its role in antibiotic resistance. To demonstrate that shorter durations of antibiotic therapy are as efficacious as longer durations for many infections, a systematic review was undertaken of English‐language articles by using PubMed to identify articles for inclusion. Additionally, infection‐specific guidelines were identified for review of recommendations. Search terms included specific infection types, randomized controlled trial (RCT), duration of therapy, treatment duration, short course, and long course. Only RCTs of single‐agent antibiotic therapy for the treatment of bacterial infections in adults were included. Independent data extraction of articles was conducted by two authors by using predefined guidance for article inclusion. In total, 23 RCTs met our criteria for inclusion. All trials compared single‐agent antibiotics for a short and long antibiotic course in six common infections: community‐acquired pneumonia, ventilator‐associated pneumonia, intraabdominal infections, skin and soft tissue infections, uncomplicated cystitis, and complicated cystitis or pyelonephritis. Clinicians can decrease net antibiotic use by recommending shorter courses where evidence supports them. Antimicrobial stewardship programs that systematically address treatment duration may significantly affect institutional antibiotic use without negatively affecting patient care.Keywords
This publication has 62 references indexed in Scilit:
- Clinicians' Knowledge, Attitudes, and Practices regarding Infections with Multidrug-Resistant Gram-Negative Bacilli in Intensive Care UnitsInfection Control & Hospital Epidemiology, 2013
- A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumoniaCritical Care, 2012
- Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic TreatmentPLOS ONE, 2012
- Economic Impact of Ventilator-Associated Pneumonia in a Large Matched CohortInfection Control & Hospital Epidemiology, 2012
- The Use of Antimicrobial Agents after Diagnosis of Viral Respiratory Tract Infections in Hospitalized Adults: Antibiotics or Anxiolytics?Infection Control & Hospital Epidemiology, 2010
- New LipoglycopeptidesDrugs, 2010
- Community-associated meticillin-resistant Staphylococcus aureusThe Lancet, 2010
- Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyBMJ, 2006
- Effect of antimicrobial agents on the ecological balance of human microfloraThe Lancet Infectious Diseases, 2001
- Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991